---
figid: PMC6770178__cancers-11-01258-g001
figtitle: Substance P/neurokinin-1 receptor (SP/NK-1R) system regulates several cell
  signaling pathways involved in cancer progression
organisms:
- NA
pmcid: PMC6770178
filename: cancers-11-01258-g001.jpg
figlink: /pmc/articles/PMC6770178/figure/cancers-11-01258-f001/
number: F1
caption: 'The substance P/neurokinin-1 receptor (SP/NK-1R) system regulates several
  cell signaling pathways involved in cancer progression. These pathways are the following:
  (a) Antiapoptotic signaling pathway (PI3K/Akt/mTOR); (b) cell proliferation signaling
  pathway (PKC, MAPKs, ERK); (c) cell migration signaling pathway (Rho-ROCK-pMLC);
  (d) Wnt signaling pathway (β-catenin, c-myc, cyclin D1); (e) AC-cAMP-PKA phosphorylation
  signaling pathway, and (f) the Warburg effect (GSK-3β). APC: Adenomatous polyposis
  coli; Dvl: Dishevelled; Fzd: Frizzled receptor; PCP: Planar cell polarity pathway;
  PDK-1: Phosphoinositide-dependent kinase-1; pMLC: Myosin light-chain kinase; TCF/LEF:
  Transcription factor/lymphoid enhancer-binding factor.'
papertitle: Neurokinin-1 Receptor Antagonists against Hepatoblastoma.
reftext: Miguel Muñoz, et al. Cancers (Basel). 2019 Sep;11(9):1258.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9491164
figid_alias: PMC6770178__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC6770178__F1
ndex: f2ede7f6-def6-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6770178__cancers-11-01258-g001.html
  '@type': Dataset
  description: 'The substance P/neurokinin-1 receptor (SP/NK-1R) system regulates
    several cell signaling pathways involved in cancer progression. These pathways
    are the following: (a) Antiapoptotic signaling pathway (PI3K/Akt/mTOR); (b) cell
    proliferation signaling pathway (PKC, MAPKs, ERK); (c) cell migration signaling
    pathway (Rho-ROCK-pMLC); (d) Wnt signaling pathway (β-catenin, c-myc, cyclin D1);
    (e) AC-cAMP-PKA phosphorylation signaling pathway, and (f) the Warburg effect
    (GSK-3β). APC: Adenomatous polyposis coli; Dvl: Dishevelled; Fzd: Frizzled receptor;
    PCP: Planar cell polarity pathway; PDK-1: Phosphoinositide-dependent kinase-1;
    pMLC: Myosin light-chain kinase; TCF/LEF: Transcription factor/lymphoid enhancer-binding
    factor.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - B3GAT1
  - TACR1
  - MTG1
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - KRAS
  - HRAS
  - NRAS
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - BMP1
  - PRCP
  - PGPEP1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AXIN1
  - AXIN2
  - APC
  - PROC
  - MTOR
  - DVL1
  - DVL1P1
  - DVL2
  - DVL3
  - IFT81
  - GSK3B
  - CTNNB1
  - PDK1
  - PDPK1
  - AKT1
  - AKT2
  - AKT3
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - RHO
  - RHOD
  - RHOA
  - RHOB
  - RHOC
  - HNF4A
  - FOS
  - FOSB
  - JUN
  - JUNB
  - JUND
  - ROCK1
  - ROCK2
  - BCL2
  - NFKB1
  - MMP7
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - LGR5
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - PC
  - SRC
  - FGR
  - FYN
  - YES1
  - MYC
  - GDP
  - GTP
  - AMPC
  - Ca
  - APC
  - Cancer
---
